BioCentury | Nov 3, 2014
Emerging Company Profile

SutroVax: Upscaled antigens

...one of its first projects, SutroVax targeted production of the malaria antigen P. falciparum surface protein 25 ( Pfs25...
...and the wheat germ system produced only "minute quantities," he said. SutroVax offered to produce Pfs25...
BioCentury | Sep 1, 2014
Company News

Burnet Institute, Artes Biotechnology, Program for Appropriate Technology in Health deal

...partners will use the Metavax platform to develop virus-like particle (VLP) vaccines containing malaria antigens Pfs25...
BioCentury | Dec 19, 2011
Clinical News

Pfs25-EPA/Alhydrogel: Phase I started

...September, the partners began an open-label, U.S. Phase I trial to evaluate 3 doses of Pfs25-EPA/Alhydrogel...
...Washington. D.C. Product: Pfs25-EPA/Alhydrogel Business: Infectious Molecular target: Not applicable Description: Vaccine consisting of recombinant Pfs25...
BioCentury | Dec 29, 2006
Clinical News

Researchers report malaria vaccine candidate

...an experimental malaria vaccine that targets the parasite inside its mosquito host. The vaccine contains Pfs25...
...its time in the mosquito's gut. The researchers reported that, in mice, protein conjugates of Pfs25...
...which causes the most severe form of malaria. The findings suggest that vaccinating with the Pfs25...
Items per page:
1 - 4 of 4